UCSD seeks spinal injury patients for 5-year stem cell test

The UC San Diego Health System has put out a call for eight spinal cord injury patients to take part in a five-year test of the safety of a new treatment involving neural stem cell research. The researchers need patients…

InVivo Therapeutics granted patent on scaffolds for SCI treatment

InVivo Therapeutics has received a Notice of Allowance from the United States Patent and Trademark Office (USPTO) for U.S. Patent Application No. 14/177,888, titled “Methods and Compositions for the Treatment of Open and Closed Wound Spinal Cord Injuries”. The application…

Dramatic growth of grafted stem cells achieved in rat spinal cord injuries

Scientists at the University of California, San Diego School of Medicine and Veterans Affairs San Diego Healthcare System have reported that neurons from human-induced pluripotent stem cells (iPSC) that were grafted into rats after a spinal cord injury have produced…

New standards proposed for reporting spinal cord injury experiments

The difficulty in replicating and directly comparing and confirming the scientific results reported by researchers worldwide who are studying new approaches to treating spinal cord injuries is slowing the translation of important new findings to patient care. Published in the…

First conclusive non-invasive measurement of neural signaling in human spinal cord

Researchers in the Vanderbilt University Institute of Imaging Science (VUIIS) have achieved the first conclusive non-invasive measurement of neural signaling in the spinal cords of healthy human volunteers. The researchers used ultra-high field functional magnetic resonance imaging (fMRI) to detect…

Borrowing strategy from simpler animals to repair damaged spinal cord nerves in humans

“This research implies that we might be able to mimic neuronal repair processes that occur naturally in lower animals, which would be very exciting,” says the study’s senior author and Salk professor Kuo-Fen Lee. The results were published in PLOS…

Final patient treated in Neuralstem phase II ALS stem cell trial

Neuralstem, Inc. announced that the final patient was treated in its Phase II trial using NSI-566 spinal cord-derived neural stem cells in the treatment of amyotrophic lateral sclerosis (ALS or Lou Gehrig’s disease). The multi-centre Phase II trial treated 15…

Unexpected stem cell factories found inside teeth

Researchers from the Karolinska Institute in Stockholm have discovered nervous system cells transforming back into stem cells in a very surprising place: inside teeth. This unexpected source of stem cells potentially offers scientists a new starting point from which to grow…

Gene inhibitor, salmon fibrin restore function lost in spinal cord injury

Scientists at UC Irvine’s Reeve-Irvine Research Center (USA) have found that a therapy combining salmon fibrin injections into the spinal cord and injections of a gene inhibitor into the brain restored voluntary motor function in a rat model of spinal cord injury, The…